Brain training for psychosis: a small step toward better school performance

NCT ID NCT04040829

Terminated Symptom relief Sponsor: Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether adding cognitive remediation therapy (a type of brain training) to supported education (help returning to school) improves academic functioning in young adults with psychotic disorders. Only 9 people enrolled before the study was stopped early. The goal was to see if the combination helps with school performance, thinking skills, and daily life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cognitive remediation therapy (behavioral intervention)
What this could lead to: If it works, this could point toward a way to help people with psychotic disorders do better in school and daily life.
What could go wrong: This trial was terminated early with only 9 participants, so results are very limited. It is too small to draw firm conclusions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSYCHOTIC DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psychotic disorder Psychotic Disorders Schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSYCHOTIC DISORDERS

Contacts and locations

Locations

Centre de recherche CERVO

Québec, Quebec, G1J2G3, Canada
Centre de recherche de l'Institut universitaire en santé mentale de Montréal

Montreal, Quebec, H1N 3V2, Canada
Centre hospitalier universitaire de Montréal

Montreal, Quebec, H2X 3E4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.